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SUMMARY: The present work discloses a procedure for preparation of human liver 
plasma membranes containing catalytically competent insulin receptor kinase. In 
addition to insulin promoted phosphorylation of the P-subunit of insulin receptor 
kinase, insulin promoted phosphorylation of pp120 and two other new proteins was 
demonstrated. The new proteins with molecular weights of 50,000 and 120,000 do 
not bind to WGA, pp120 antibody or insulin receptor antibody, but bind to the 
antiphosphotyrosyl antibody. The identity and physiological significance of these 
putative substrates for insulin receptor kinase remains to be established. @ 1987 
Academic Press, Inc. 
Insulin promotes autophosphorylation of the P-subunit of its receptor (l-111, 
and concomitantly activates the receptor as a tyrosyl kinase (12,131. In addition to 
catalyzing phosphorylation of exogenous substrates in cell-free systems (14-19), 
insulin receptor kinase appears to catalyze phosphorylation of several endogenous 
substrates with molecular weights in the range of 15,000-185,OO in several animal 
models and cell lines (20-26). The fact that liver is a major insulin target together 
with the possibility that endogenous substrates for insulin receptor kinase may 
function as second messengers, makes it important to characterize the reactions of 
insulin receptor with other membrane proteins. Such studies have been hampered, 
however, by the difficulty of obtaining liver plasma membranes with catalytically 
competent insulin receptor. This problem may be due in part to the high 
concentration of proteinases in liver cells, Previous studies have demonstrated that 
insulin receptor is sensitive to proteolytic nicking at the C-terminal end of its 8- 
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subunits (27), that a large fraction of the insulin receptor in human placental 
membrane preparations, although competent to bind insulin, is proteolytically 
nicked in one or both of its P-subunits (28,29), and that this proteolytically nicked 
receptor is incompetent to undergo insulin promoted autophosphorylation and 
activation as a tyrosyl kinase (6,8). The present study discloses a procedure for 
preparing human liver plasma membranes containing catalytically competent 
insulin receptor kinase. Additionally, this work reports insulin promoted 
phosphorylation of endogenous or plasma membrane associated substrates, in liver 
plasma membranes from normal individuals, a morbidly obese individual with type 
II diabetes and a nondiabetic morbidly obese individual. 
MATERIALS AND METHODS 
Liver plasma membranes preparation: Liver biopsies (l-2g) were obtained 
from 2 patients undergoing elective cholecystectomy, and 3 brain-dead organ donors 
without any known metabolic diseases, and from 2 morbidly obese patients, one with 
type II diabetes and the other with normal glucose tolerance test, undergoing an 
elective gastric bypass procedure, Written consent was obtained from all patients 
after they were informed about the nature and potential risks of the study. 
The liver tissue was homogenized in 50 ml of 1 mM NaHC03 buffer, containing 
0.5 mM CaClz pH 7.5 as described by Ray (30). The plasma membranes were 
isolated by the aqueous two-phase polymer method of Lesko et a2. (31) as we have 
previously described (32). The membranes were suspended in 50 mMTris buffer, pH 
7.4 and kept at -70°C until they were used. All the buffers contained 2 pM leupeptin, 
2 pM pepstatin, 1 mM phenylmethylsulfonyl fluoride, 0.1 mg/ml bacitracin, 1000 
U/ml aprotinin and 1 mM vanadate. The addition of these proteinase and 
phosphatase inhibitors was found to be essential for the activation of insulin receptor 
kinase by insulin. 
Phosphorylation of liver plasma membranes: Liver plasma membranes (- 50 pg 
protein) were preincubated in 500 pl of Krebs-Ringer bicarbonate buffer pH 7.4 
containing 3% bovine serum albumin and the above mentioned proteinase and 
phosphatase inhibitors in the presence and absence of insulin 1 x 10.7M for 16 hours 
or 1 hour at 4°C. Then [y-32Pl ATP (100 pM) was added in the presence of 5 mM 
MnClz and 5 mM MgC12 and the reaction continued for an additional one hour at 
4°C. The reaction was stopped with an equal volume of 50 mM HEPES buffer pH 7.4 
containing 10 mM EDTA, 100 mM NaF, 20 mM pyrophosphate and 4 mM ATP. The 
membranes were pelleted by centrifugation at 10,000 x g for 30 minutes and then 
solubilized for 1 hour at 4°C in 50 mM HEPES pH 7.4, containing 1% Triton X-100 
and above-mentioned inhibitors. The mixture was then centrifuged at 100,000 x g 
for 60 minutes and the crude solubilized extract was partially purified by wheat 
germ agglutinin affinity chromatography (WGA) as previously reported (33). Then, 
both the material absorbed and that nonabsorbed by WGA were immunoprecipitated 
by our insulin receptor antibodies (33), antiphosphotyrosine antibodies (29) and by 
pp120 antibodies (20). The immunoprecipitates were subjected to polyacrylamide 
gel electrophoresis after reduction (34) followed by autoradiography. In some 
experiments, comparison of phosphoamino acid analysis of P-subunit of insulin 
receptors in both the human liver plasma membrane preparation and the solubilized 
receptor preparation was determined by a described method (35). Also, for 
comparison between different patients, the 1251 insulin binding activity of plasma 
membrane and solubilized receptors was equalized before performing 
phosphorylation reaction (33). 
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Figure 1. 
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Autoradiogram of insulin-stimulated autophosphorylation of the p- 
subunit of solubilized insulin receptors or plasma membranes and 
phosphoamino acid analysis of the P-subunit of insulin receptors from 
human liver. 
RESULTS 
Studies of insulin promoted phosphorylation of insulin receptor were performed 
using insulin receptor antibodies to precipitate insulin receptor selectively. The 
observations depicted in Fig. 1 indicate that the human liver plasma membranes 
obtained by the procedure described under “MATERIALS AND METHODS” 
contains insulin receptor that is competent to undergo insulin promoted tyrosyl 
phosphorylation. The success of the procedure was dependent on the presence of the 
indicated proteinase and phosphatase inhibitors. Omission of one or more of these 
inhibitors resulted in a marked decrease in the yield of catalytically competent 
insulin receptor (data not shown). The observations depicted in Fig. 1 also 
demonstrate that the extent of autophosphorylation relative to insulin binding was 
the same for insulin receptor in plasma membranes and insulin receptor partially 
purified from solubilized membranes by lectin chromatography. This finding 
suggests that these procedures did not result in selective loss of kinase activity as 
might be expected if P-chain nicking by membrane-bound proteinases occurred 
during solubilization and lectin chromatography. Phosphoamino acid analysis (Fig. 
1) revealed that (as expected) autophosphorylation of insulin receptor kinase 
occurred predominantly at tyrosyl residues. 
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Figure 2. 
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Autoradiogram of insulin-stimulated phosphorylated human liver 
plasma membranes absorbed by WGA-Sepharose and immuno- 
precipitated by insulin receptor antibodies, pp120 antibodies and 
phosphotyrosine antibodies. 
Studies of insulin promoted phosphorylation of insulin receptor kinase and 
endogenous proteins in plasma membranes proteins are illustrated in Fig. 2 and 3. 
In these studies plasma membranes were exposed to [y-3zPlATP in the presence and 
absence of insulin for one hour, after which time the reaction was quenched, the 
membranes solubilized and subjected to lectin chromatography on immobilized 
WGA. Figure 2 depicts an autoradiogram of SDS-PAGE gels of material that was 
absorbed and eluted from WGA and immunoprecipitated by either insulin receptor 
antibody, phosphotyrosyl binding antibodies or an antibody to ~~120, and 
endogenous substrate present in preparations of insulin receptor partially purified 
from solubilized rat microsomes by affinity chromatography on WGA (20). The 
appearance of azP-labeled material in the left and right panels of Fig. 2 having a 
mobility similar to that expected for the P-subunit of insulin receptor kinase is 
consistent with the fact that insulin receptor is a WGA-binding glycoprotein which, 
after undergoing insulin promoted tyrosyl phosphorylation, binds to phosphotyrosyl 
binding antibodies. 
The center panel in Fig. 2 shows that insulin receptor in human liver 
membranes promotes phosphorylation of pp120, a protein recently shown to be 
present in liver plasma membranes from rat, monkey and rabbit (20,361. Although 
pp120 present in solubilized insulin receptor preparation from rat liver microsomes 
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Figure 3. Autoradiogram of insulin-stimulated phosphorylated human liver 
plasma membranes not absorbed by WGA-Sepharose and immuno- 
precipitated by insulin receptor antibodies, pp120 antibodies and 
phosphotyrosine antibodies. 
undergoes insulin promoted tyrosyl phosphorylation, it is not adsorbed by the 
phosphotyrosyl binding antibodies (36). The right panel in Fig. 2 indicates that 
human liver pp120 that had been phosphorylated in intact plasma membranes is 
also not adsorbed by the phosphotyrosyl binding antibodies. 
Figure 3 depicts an analysis of phosphorylation in the material that did not 
bind to immobilized WGA. This analysis indicates the existence of two new 
endogenous or plasma membrane associated substrates for insulin receptor kinase 
that migrate on SDS-PAGE (after reduction) with molecular weights of 50,000 and 
120,000. The fact that these proteins do not bind to WGA, pp120 antibody or insulin 
receptor antibody, but bind to the antiphosphotyrosyl antibody, suggests that they 
are tyrosyl phosphorylated and distinct from insulin receptor, pp120 and 
degradation products thereof. 
In light of the report that preparations of insulin receptor partially purified 
from solubilized hepatic receptors from morbidly obese patients with type II diabetes 
exhibit depressed activity toward an artificial exogenous substrate (32), we were 
prompted to determine the behavior of insulin receptor in intact plasma membranes 
from a morbidly obese diabetic and a morbidly obese nondiabetic. The observations 
1012 
Vol. 149, No. 3, 1987 BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS 
CONTROL NIDDM 
Mr x 10m3 
116- 
Insulin 
1 x 10-7M -+ -+ -+ -+ 
Receptor PP 120 Receptor PP120 
Antibody Antibody Antibody Antibody 
Figure 4. Autoradiogram of insulin-stimulated phosphorylated human liver 
plasma membranes absorbed by WGA-Sepharose and immuno- 
precipitated by insulin receptor antibodies and pp120 antibodies. 
depicted in Fig. 4 indicate that liver plasma membranes from the morbidly obese 
diabetic exhibit markedly less insulin promoted phosphorylation of insulin receptor 
kinase and pp120 relative to that from a morbidly obese nondiabetic control. 
DISCUSSION 
Determination of the molecular basis for the dysfunctions associated with type 
II diabetes is likely to require more information concerning the reactions of insulin 
and insulin receptor in liver, a major insulin target. Although we have developed 
methodologies to isolate insulin responsive human hepatocytes (321, studies of 
insulin receptor kinase in these cells are difficult, mainly because of the relatively 
small number of cells available from intraoperative biopsy material (l-2 g). 
Moreover, studies of insulin receptor partially purified from solubilized human 
plasma membranes while informative (32), are limited, since proteins that interact 
with the receptor in the plasma membrane may be lost during solubilization and 
purification. Thus, the studies of insulin receptor in human liver plasma 
membranes reported in the present work revealed the presence of two previously 
undetected endogenous or plasma membrane associated potential substrates for 
insulin receptor kinase. The identity of these putative substrates for insulin 
receptor kinase and the physiological significance (if any) of their insulin promoted 
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phosphorylation remains to be established. In this regard it is interesting to note 
that one of the putative substrates exhibits a similar molecular weight to that of the 
insulin stimulated S6 kinase reported by Tabarini et al. (25) to be present in 3T3-Ll 
cells. 
The observation of insulin promoted phosphorylation of ~~120, reported in the 
present work indicates that pp120 is present in human liver plasma membranes, and 
that solubilization of the plasma membrane is not a prerequisite for phosphorylation 
of pp120. This finding is consistent with the notion that pp120 is accessible to 
insulin receptor kinase in intact cells. The fact that pp120 was detected in liver from 
several species, but could not be detected in several other tissues including rat brain, 
skeletal muscle, heart, kidney, and adipocytes suggested that pp120 is a liver 
specific protein (361. This finding together with the observation that pp120 
undergoes insulin promoted phosphorylation in intact plasma membranes suggests 
the possibility that pp120 is a determinant of the unique effects of insulin on 
hepatocyte metabolism. It remains to be established whether pp120 in human liver 
membranes undergoes tyrosyl phosphorylation as does the pp120 present in 
preparations of insulin receptor partially purified from solubilized rat liver 
microsomes. The failure of the phosphotyrosyl binding antibodies to adsorb tyrosyl 
phosphorylated pp120 from rat liver microsomes is consistent with our unpublished 
observations that although these antibodies bind most phosphotyrosyl containing 
proteins, certain tyrosyl phosphorylated proteins and peptides bind poorly to the 
phosphotyrosyl binding antibodies. 
Since depressed autophosphorylation of insulin receptor kinase is correlated 
with incomplete activation of the kinase activity of insulin receptor, the reduced 
insulin promoted phosphorylation of insulin receptor and pp120 in plasma 
membranes from a diabetic morbidly obese individual is consistent with the 
previously reported observation that solubilized partially purified insulin receptor 
from adipose (37) and hepatic tissue (32) from this individual (and other morbidly 
obese type II diabetics) exhibited reduced insulin stimulated kinase activity toward 
an exogenous substrate. It is interesting to note, however, that in contrast to the 
behavior of insulin receptor partially purified from adipocytes and hepatocytes, 
solubilized insulin receptor partially purified from skeletal muscle of the type II 
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diabetic studied in this report (as well as other morbidly obese type II diabetics) 
appears to undergo insulin promoted autophosphorylation in a manner 
indistinguishable from that of insulin receptor from normal skeletal muscle tissue 
(33). This finding suggests the possibility that the altered insulin responsiveness of 
insulin receptor characteristic of certain types of type II diabetes may be dependent 
on receptor locale. 
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